Ignite Creation Date:
2024-05-06 @ 7:29 AM
Last Modification Date:
2024-10-26 @ 11:49 AM
Study NCT ID:
NCT02545465
Status:
COMPLETED
Last Update Posted:
2017-05-24
First Post:
2015-09-08
Brief Title:
A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
Retrospective Chart Review of Patients With PAH or InoperablePersistentRecurrent CTEPH Who Transition Their PH Treatment to Adempas
Status:
COMPLETED
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAPTURE
Brief Summary:
The aim of this study is to understand the treatment patterns in patients with Pulmonary Arterial Hypertension PAH or Chronic Thromboembolic Pulmonary Hypertension CTEPH during a switch of treatment to Adempas in real-life clinical practice
In addition this study will describe patient demographics and reason for switching
In addition this study will describe patient demographics and reason for switching
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| AD1501 | OTHER | Company Internal | None |